Today: 7 February 2026
Subscribe
Browse Category

Price Targets News 17 December 2025 - 22 December 2025

Analog Devices (ADI) Stock Week Ahead: Holiday-Shortened Trading, Fresh Price-Target Hikes, and Key Catalysts for Dec. 22–26, 2025

Analog Devices (ADI) Stock Week Ahead: Holiday-Shortened Trading, Fresh Price-Target Hikes, and Key Catalysts for Dec. 22–26, 2025

Analog Devices, Inc. (NASDAQ: ADI) heads into the Christmas week with investors balancing three storylines: a holiday-shortened trading schedule, a run of upbeat sell-side revisions, and new industry chatter about pricing power heading into 2026. As of the last full trading session before this report, ADI ended Friday, December 19, 2025, at $274.44, after a choppy week that included a midweek slide and a rebound attempt into the close. ADI remains not far from its 52-week high of $284.23, leaving the stock in a “near-the-top, but not breaking out” posture going into thin holiday liquidity. Investing.com Below is what matters
22 December 2025
·····
Procter & Gamble (PG) Stock News Today: Jefferies Upgrade Spotlight, Fresh Price Targets, and What to Watch Into 2026

Procter & Gamble (PG) Stock News Today: Jefferies Upgrade Spotlight, Fresh Price Targets, and What to Watch Into 2026

Procter & Gamble Company (The) (NYSE: PG) is ending 2025 with a familiar investor debate—is this consumer-staples bellwether a defensive bargain after a weak year, or a “steady but capped” stock until growth re-accelerates? As of the latest available quote from late December trading, PG is around $144.46. Below is a roundup of the latest coverage and analysis dated from December 20, 2025 onward, plus the most relevant near-term forecasts, Street targets, and the key catalysts that could drive the next move. What’s new since December 20, 2025: the “reassess PG” moment A prominent theme in fresh analysis on December
20 December 2025
·····
CSL Limited Stock (ASX:CSL): Latest News, Buyback Update, Analyst Price Targets and 2026 Outlook (20 Dec 2025)

CSL Limited Stock (ASX:CSL): Latest News, Buyback Update, Analyst Price Targets and 2026 Outlook (20 Dec 2025)

CSL Limited (ASX:CSL; USOTC:CSLLY) has spent 2025 reminding the market of an awkward truth: even “defensive” healthcare giants can deliver very non-defensive share price swings. After a year dominated by vaccine-market volatility, a reshaped strategy for CSL Seqirus, and investor nerves around China pricing, the stock heads into late December with a familiar question hanging in the air—is CSL Limited stock a bruised blue-chip bargain, or a business still working through its hardest chapter? TradingView+1 As of the latest available pricing data around A$175 (weekend markets closed), CSL is trading much closer to its 52‑week lows than its highs (52‑week
20 December 2025
····
Starbucks Stock (SBUX) Today: Analyst Price Targets, 2026 Forecasts, and the Key Headlines Driving Shares on Dec. 19, 2025

Starbucks Stock (SBUX) Today: Analyst Price Targets, 2026 Forecasts, and the Key Headlines Driving Shares on Dec. 19, 2025

Starbucks Corporation stock (NASDAQ: SBUX) is trading slightly lower on Friday, December 19, 2025, as investors balance a “turnaround-in-progress” narrative against real-world crosscurrents: elevated coffee costs, labor disruption risk, and a still-evolving international strategy—especially in China. As of early afternoon, Starbucks shares were $88.77, down $0.65 (-0.72%). MarketBeat Below is a full, up-to-the-minute look at the news flow, forecasts, and analyst views shaping SBUX today—plus the specific issues Wall Street is watching into 2026. Starbucks stock price today: what’s happening with SBUX on Dec. 19, 2025? After a strong stretch of “green shoots” optimism around CEO Brian Niccol’s operational reset,
19 December 2025
····
PepsiCo Stock (PEP) News, Forecasts and Analyst Targets: Citi Lifts Price Target to $170 as Turnaround Plan and Leadership Changes Take Center Stage (Dec. 18, 2025)

PepsiCo Stock (PEP) News, Forecasts and Analyst Targets: Citi Lifts Price Target to $170 as Turnaround Plan and Leadership Changes Take Center Stage (Dec. 18, 2025)

PepsiCo, Inc. (NASDAQ: PEP) ended Thursday, December 18, 2025, in the high-$140s as investors balanced a fresh wave of analyst commentary with an activist-driven push for improved execution, a newly announced leadership reshuffle, and a legal headline that has added near-term uncertainty. StockAnalysis+2TradingView+2 While understood as a “defensive” consumer-staples name, PepsiCo is being treated more like a turnaround story in late 2025: the market is closely tracking whether pricing, promotions, portfolio pruning, and operational changes can stabilize North America performance and re-accelerate volumes in 2026. PepsiCo+2AP News+2 PepsiCo stock price today: PEP closes near $149.7 on Dec. 18 PepsiCo shares
18 December 2025
····
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer (NYSE: PFE) stock is trying to regain its footing on Thursday, December 18, 2025, after a volatile mid-December stretch that put the spotlight back on three recurring themes for shareholders: the post-COVID revenue reset, looming loss-of-exclusivity (LOE) headwinds, and whether Pfizer’s rebuilt pipeline can drive durable growth later this decade. As of 18:26 UTC (1:26 p.m. ET) on Dec. 18, Pfizer shares traded around $25.04, essentially flat on the day. What’s driving Pfizer stock on Dec. 18, 2025 Here are the major, market-moving Pfizer headlines and developments investors are digesting today: Pfizer stock price check: stability after a sharp
18 December 2025
··
Johnson & Johnson Stock (JNJ) News Today: FDA Approvals, Analyst Price Targets, and the 2026 Outlook (Dec. 18, 2025)

Johnson & Johnson Stock (JNJ) News Today: FDA Approvals, Analyst Price Targets, and the 2026 Outlook (Dec. 18, 2025)

Johnson & Johnson (NYSE: JNJ) stock traded around $208 on Thursday, December 18, 2025, with shares modestly lower on the session as investors weighed a busy late-year news cycle that includes fresh FDA wins in MedTech and oncology, new Wall Street target updates, and the continued legal overhang from talc litigation. For long-term holders, the story remains familiar: J&J is a diversified healthcare bellwether spanning Innovative Medicine and MedTech—a blend that can cushion volatility, but also means the stock tends to react to a wide mix of regulatory, clinical, litigation, and analyst-driven headlines. Reuters Below is what matters most for
18 December 2025
····
Bank of America BAC Stock on Dec 18 2025: New $63 Price Target, Cooling Inflation, and the 2026 Setup

Bank of America BAC Stock on Dec 18 2025: New $63 Price Target, Cooling Inflation, and the 2026 Setup

December 18, 2025 — Bank of America Corporation’s stock (NYSE: BAC) is back in the spotlight as Wall Street digests a cooler inflation print, fresh analyst price-target moves, and a late-year resurgence in dealmaking that could reshape big-bank earnings momentum into 2026. Key takeaways for Bank of America stock today Bank of America stock price today Bank of America shares were under active watch Thursday as investors balanced “risk-on” relief from inflation with the market’s evolving rate path narrative. As of the latest available quote on Dec. 18, BAC traded near $54.02, down about 1% on the session, after opening
18 December 2025
·····
Eaton Stock (NYSE: ETN) News Today, Dec. 18, 2025: Why Shares Fell, Wall Street Price Targets, and the Data‑Center Growth Story

Eaton Stock (NYSE: ETN) News Today, Dec. 18, 2025: Why Shares Fell, Wall Street Price Targets, and the Data‑Center Growth Story

Eaton Corporation plc (NYSE: ETN) is ending 2025 with a familiar mix of investor emotions: admiration for its “electrification + data centers” growth narrative… and anxiety about valuation, volatility, and whether the next leg of demand arrives on schedule. As of December 18, 2025, ETN is hovering around $315.82, after a sharp 4.28% drop in the prior session (Wednesday, Dec. 17). MarketWatch That pullback matters not just because the move was large, but because it arrived with unusually heavy trading volume—a classic sign that big investors were repositioning rather than casually drifting. MarketWatch Below is a detailed roundup of the
18 December 2025
·····
Genting Singapore Stock (SGX: G13) on Dec. 18, 2025: Credit Outlook Headlines, RWS 2.0 Spending, and Analyst Price Targets

Genting Singapore Stock (SGX: G13) on Dec. 18, 2025: Credit Outlook Headlines, RWS 2.0 Spending, and Analyst Price Targets

Genting Singapore Limited (SGX: G13) is back in the spotlight on December 18, 2025, as investors weigh a familiar casino-industry trade-off: big, long-horizon expansion spending now versus earnings (and potentially higher valuation) later. The immediate catalyst isn’t a fresh earnings print from the Singapore-listed operator of Resorts World Sentosa (RWS)—it’s the latest wave of credit-rating commentary on the wider Genting group’s spending ambitions, with Singapore explicitly cited as part of the investment load. The Business Times+1 At the same time, “Street math” remains broadly constructive: multiple data aggregators show consensus 12‑month targets above the recent trading level, even as the
18 December 2025
····
IonQ (IONQ) Stock News Today (Dec. 17, 2025): Wedbush Joins Jefferies With Fresh Coverage—Latest Headlines, Price Targets, and 2026 Outlook

IonQ (IONQ) Stock News Today (Dec. 17, 2025): Wedbush Joins Jefferies With Fresh Coverage—Latest Headlines, Price Targets, and 2026 Outlook

Updated: Wednesday, December 17, 2025 IonQ, Inc. (NYSE: IONQ) is back in the spotlight on December 17, 2025—this time not because of earnings, but because Wall Street is rapidly building out coverage of the “pure-play” quantum computing names. Wedbush initiated coverage on IonQ today with an Outperform rating and a $60 price target, one day after Jefferies initiated with a Buy and a much higher $100 target. Investing.com+2Investing.com+2 Despite those bullish headlines, IonQ stock is down sharply intraday. As of 19:16 UTC (mid-afternoon in New York), IONQ traded at $46.95, down about 5.48% on the day, after opening above $50
17 December 2025
····
Fermi Inc (FRMI) Stock News Today: Why Shares Are Swinging, Latest SEC Filing, and Analyst Price Targets (Dec. 17, 2025)

Fermi Inc (FRMI) Stock News Today: Why Shares Are Swinging, Latest SEC Filing, and Analyst Price Targets (Dec. 17, 2025)

Fermi Inc. (NASDAQ: FRMI; LSE: FRMI) stock is back in the spotlight on Wednesday, December 17, 2025, after another volatile session that followed last week’s sharp selloff and Tuesday’s strong rebound. In early afternoon trading, FRMI was changing hands around $8.85, down about 9% on the day after opening near $10.00 and sliding as low as $8.75, with volume approaching 4.25 million shares. The latest move comes as investors digest a key development disclosed in a recent SEC filing: a prospective “first tenant” for Fermi’s flagship Project Matador in Texas terminated an agreement that could have advanced up to $150
17 December 2025
····
1 2 3 4 … 6

Stock Market Today

Diageo share price slips into the weekend as investors eye Feb. 25 results

Diageo share price slips into the weekend as investors eye Feb. 25 results

7 February 2026
Diageo shares closed down 1.48% at 1,760 pence on Friday, trailing a 0.59% gain in the FTSE 100. An updated analyst consensus points to a 2.0% fall in first-half organic net sales ahead of interim results due Feb. 25. Trading volume was light, and the stock remains over 22% below its 52-week high.
National Grid share price: what to know before London reopens after BoE signal

National Grid share price: what to know before London reopens after BoE signal

7 February 2026
National Grid shares closed at 1,285 pence in London on Friday, up 0.23%. The Bank of England held rates at 3.75% after a close vote, signaling possible cuts if inflation falls. National Grid announced a wireless power transmission study with Space Solar and marked five years of IFA2 interconnector operations. Its U.S. ADR ended at $88.06, up $1.17.
BAE Systems share price rises into weekend — what to watch before Monday’s London open

BAE Systems share price rises into weekend — what to watch before Monday’s London open

7 February 2026
BAE Systems shares closed up 1.2% at 1,879 pence on Friday, tracking gains in European defence stocks. The company’s market value stands near £54.8 billion. Investors await BAE’s full-year results on Feb. 18 for updates on cash returns and orders. GXO Logistics renewed and expanded its contract to support BAE’s Type 26 frigate program in Scotland.
Go toTop